Biotech lobby optimistic on intellectual property reforms


BIOTECanada sides with research-based pharma on CETA negotiations, but experts warn that tougher protections could hurt Canadian researchers.

By Chris Plecash

PUBLISHED : Friday, Sept. 6, 2013 9:20 PM

If you are already a subscriber


Subscribe to The Hill Times

Subscribe to the digital and/or print editions and get instant access to The Hill Times online.


Quick Purchase

Purchase Story Issue in electronic format (PDF) for $5.00.